These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 24532739)

  • 1. Managing latent tuberculosis in UK renal transplant units: how does practice compare with published guidance?
    Maynard-Smith L; Fernando B; Hopkins S; Harber M; Lipman M
    Clin Med (Lond); 2014 Feb; 14(1):26-9. PubMed ID: 24532739
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Missed opportunities for tuberculosis prevention among patients accessing a UK HIV service.
    Rickman HM; Miller RF; Morris-Jones S; Kellgren L; Edwards SG; Grant AD
    Int J STD AIDS; 2018 Oct; 29(12):1234-1237. PubMed ID: 29749875
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Management of latent Mycobacterium tuberculosis infection: WHO guidelines for low tuberculosis burden countries.
    Getahun H; Matteelli A; Abubakar I; Aziz MA; Baddeley A; Barreira D; Den Boon S; Borroto Gutierrez SM; Bruchfeld J; Burhan E; Cavalcante S; Cedillos R; Chaisson R; Chee CB; Chesire L; Corbett E; Dara M; Denholm J; de Vries G; Falzon D; Ford N; Gale-Rowe M; Gilpin C; Girardi E; Go UY; Govindasamy D; D Grant A; Grzemska M; Harris R; Horsburgh CR; Ismayilov A; Jaramillo E; Kik S; Kranzer K; Lienhardt C; LoBue P; Lönnroth K; Marks G; Menzies D; Migliori GB; Mosca D; Mukadi YD; Mwinga A; Nelson L; Nishikiori N; Oordt-Speets A; Rangaka MX; Reis A; Rotz L; Sandgren A; Sañé Schepisi M; Schünemann HJ; Sharma SK; Sotgiu G; Stagg HR; Sterling TR; Tayeb T; Uplekar M; van der Werf MJ; Vandevelde W; van Kessel F; van't Hoog A; Varma JK; Vezhnina N; Voniatis C; Vonk Noordegraaf-Schouten M; Weil D; Weyer K; Wilkinson RJ; Yoshiyama T; Zellweger JP; Raviglione M
    Eur Respir J; 2015 Dec; 46(6):1563-76. PubMed ID: 26405286
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modeling the Impact of Recommendations for Primary Care-Based Screening for Latent Tuberculosis Infection in California.
    Parriott A; Kahn JG; Ashki H; Readhead A; Barry PM; Goodell AJ; Flood J; Shete PB
    Public Health Rep; 2020; 135(1_suppl):172S-181S. PubMed ID: 32735191
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Positivity rate of interferon-γ release assays for estimating the prevalence of latent tuberculosis infection in renal transplant recipients in Japan.
    Igari H; Akutsu N; Ishikawa S; Aoyama H; Otsuki K; Hasegawa M; Maruyama M; Tsuyuzaki M; Suzuki K; Saigo K
    J Infect Chemother; 2019 Jul; 25(7):537-542. PubMed ID: 30905632
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnostic potential of interferon-gamma release assay to detect latent tuberculosis infection in kidney transplant recipients.
    Edathodu J; Varghese B; Alrajhi AA; Shoukri M; Nazmi A; Elgamal H; Aleid H; Alrabiah F; Ashraff A; Mahmoud I; Al-Hajoj S
    Transpl Infect Dis; 2017 Apr; 19(2):. PubMed ID: 28170135
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment guidelines for latent tuberculosis infection.
    ;
    Kekkaku; 2014 Jan; 89(1):21-37. PubMed ID: 24654427
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effectiveness and cost-effectiveness of screening for latent tuberculosis among migrants in the EU/EEA: a systematic review.
    Greenaway C; Pareek M; Abou Chakra CN; Walji M; Makarenko I; Alabdulkarim B; Hogan C; McConnell T; Scarfo B; Christensen R; Tran A; Rowbotham N; van der Werf MJ; Noori T; Pottie K; Matteelli A; Zenner D; Morton RL
    Euro Surveill; 2018 Apr; 23(14):. PubMed ID: 29637889
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Accurate diagnosis of latent tuberculosis in children, people who are immunocompromised or at risk from immunosuppression and recent arrivals from countries with a high incidence of tuberculosis: systematic review and economic evaluation.
    Auguste P; Tsertsvadze A; Pink J; Court R; Seedat F; Gurung T; Freeman K; Taylor-Phillips S; Walker C; Madan J; Kandala NB; Clarke A; Sutcliffe P
    Health Technol Assess; 2016 May; 20(38):1-678. PubMed ID: 27220068
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of interferon-γ release assays, QuantiFERON TB-GIT and T-Spot.TB, in renal transplantation.
    Ishikawa S; Igari H; Akutsu N; Tsuyuzaki M; Aoyama H; Hasegawa M; Otsuki K; Maruyama M; Saigo K; Suzuki K; Yamagishi F
    J Infect Chemother; 2017 Jul; 23(7):468-473. PubMed ID: 28438462
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Contribution of interferon-γ release assays (IGRAs) to the diagnosis of latent tuberculosis infection after renal transplantation.
    Hadaya K; Bridevaux PO; Roux-Lombard P; Delort A; Saudan P; Martin PY; Janssens JP
    Transplantation; 2013 Jun; 95(12):1485-90. PubMed ID: 23694948
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tuberculosis screening among HIV-infected patients: tuberculin skin test vs. interferon-gamma release assay.
    Adams JW; Howe CJ; Andrews AC; Allen SL; Vinnard C
    AIDS Care; 2017 Dec; 29(12):1504-1509. PubMed ID: 28486818
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A prospective cohort study of latent tuberculosis in adult close contacts of active pulmonary tuberculosis patients in Korea.
    Park SH; Lee SJ; Cho YJ; Jeong YY; Kim HC; Lee JD; Kim HJ; Menzies D
    Korean J Intern Med; 2016 May; 31(3):517-24. PubMed ID: 27052266
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Latent tuberculosis infection and renal transplantation - Diagnosis and management.
    Krishnamoorthy S; Kumaresan N; Zumla A
    Int J Infect Dis; 2019 Mar; 80S():S73-S76. PubMed ID: 30738187
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mycobacterium tuberculosis: Active disease and latent infection in a renal transplant cohort.
    Rafiei N; Williams J; Mulley WR; Trauer JM; Jenkin GA; Rogers BA
    Nephrology (Carlton); 2019 May; 24(5):569-574. PubMed ID: 29660203
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Prevalence of Latent Tuberculosis Infection in the United States.
    Mancuso JD; Diffenderfer JM; Ghassemieh BJ; Horne DJ; Kao TC
    Am J Respir Crit Care Med; 2016 Aug; 194(4):501-9. PubMed ID: 26866439
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intention of physicians to implement guidelines for screening and treatment of latent tuberculosis infection in HIV-infected patients in The Netherlands: a mixed-method design.
    Evenblij K; Verbon A; van Leth F
    BMC Public Health; 2016 Sep; 16(1):915. PubMed ID: 27585867
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Latent tuberculosis infection: Opportunities and challenges.
    Chee CBE; Reves R; Zhang Y; Belknap R
    Respirology; 2018 Oct; 23(10):893-900. PubMed ID: 29901251
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Management of paediatric tuberculosis in leading UK centres: unveiling consensus and discrepancies.
    Turkova A; Welch SB; Paton JY; Riordan A; Williams B; Patel SV; Clark JE; Bernatoniene J; Doerholt K; Child F; Walters S; Riddell A; Shingadia D; Liebeschuetz S; Kampmann B
    Int J Tuberc Lung Dis; 2014 Sep; 18(9):1047-56. PubMed ID: 25189551
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of the usefulness of interferon-gamma release assays and the tuberculin skin test for the detection of latent Mycobacterium tuberculosis infections in Korean rheumatic patients who are candidates for biologic agents.
    Kim JH; Won S; Choi CB; Sung YK; Song GG; Bae SC
    Int J Rheum Dis; 2015 Mar; 18(3):315-22. PubMed ID: 25351815
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.